PharVision Advisers LLC bought a new stake in Eastman Chemical Company (NYSE:EMN - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,242 shares of the basic materials company's stock, valued at approximately $462,000. Eastman Chemical comprises approximately 0.6% of PharVision Advisers LLC's portfolio, making the stock its 19th biggest position.
Several other large investors also recently modified their holdings of the stock. Brighton Jones LLC purchased a new position in Eastman Chemical in the fourth quarter valued at approximately $202,000. Ameriprise Financial Inc. grew its stake in shares of Eastman Chemical by 2.5% during the 4th quarter. Ameriprise Financial Inc. now owns 432,294 shares of the basic materials company's stock worth $39,497,000 after acquiring an additional 10,546 shares during the period. BNP Paribas Financial Markets increased its holdings in Eastman Chemical by 46.2% in the 4th quarter. BNP Paribas Financial Markets now owns 236,042 shares of the basic materials company's stock worth $21,555,000 after acquiring an additional 74,575 shares during the last quarter. Baird Financial Group Inc. raised its stake in Eastman Chemical by 4.2% in the 4th quarter. Baird Financial Group Inc. now owns 19,166 shares of the basic materials company's stock valued at $1,751,000 after acquiring an additional 768 shares during the period. Finally, Captrust Financial Advisors lifted its holdings in Eastman Chemical by 1.7% during the fourth quarter. Captrust Financial Advisors now owns 25,122 shares of the basic materials company's stock valued at $2,294,000 after purchasing an additional 421 shares during the last quarter. Hedge funds and other institutional investors own 83.65% of the company's stock.
Eastman Chemical Price Performance
Shares of NYSE EMN traded down $2.56 during mid-day trading on Wednesday, reaching $65.04. 2,356,584 shares of the company were exchanged, compared to its average volume of 1,547,654. The stock has a market capitalization of $7.47 billion, a PE ratio of 9.13, a PEG ratio of 6.58 and a beta of 1.25. The company has a quick ratio of 0.78, a current ratio of 1.68 and a debt-to-equity ratio of 0.81. Eastman Chemical Company has a 52 week low of $56.78 and a 52 week high of $114.50. The company's 50 day moving average price is $71.38 and its 200 day moving average price is $78.66.
Eastman Chemical (NYSE:EMN - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The basic materials company reported $1.60 earnings per share for the quarter, missing analysts' consensus estimates of $1.72 by ($0.12). The firm had revenue of $2.29 billion for the quarter, compared to analysts' expectations of $2.32 billion. Eastman Chemical had a net margin of 8.96% and a return on equity of 15.24%. The business's quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the business posted $2.15 earnings per share. Eastman Chemical has set its Q3 2025 guidance at 1.250-1.250 EPS. Sell-side analysts forecast that Eastman Chemical Company will post 8.55 earnings per share for the current fiscal year.
Eastman Chemical Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 7th. Stockholders of record on Monday, September 15th will be paid a $0.83 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $3.32 dividend on an annualized basis and a dividend yield of 5.1%. Eastman Chemical's dividend payout ratio is 46.63%.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on EMN shares. KeyCorp set a $79.00 price target on shares of Eastman Chemical and gave the company an "overweight" rating in a research report on Monday, August 4th. Mizuho reduced their price target on Eastman Chemical from $92.00 to $80.00 and set an "outperform" rating for the company in a research report on Friday, August 1st. Citigroup decreased their price objective on Eastman Chemical from $90.00 to $68.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. The Goldman Sachs Group reduced their target price on Eastman Chemical from $87.00 to $65.00 and set a "neutral" rating for the company in a report on Thursday, August 7th. Finally, UBS Group decreased their price target on Eastman Chemical from $107.00 to $101.00 and set a "buy" rating on the stock in a research report on Wednesday, July 9th. Eight analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Eastman Chemical presently has an average rating of "Moderate Buy" and an average price target of $87.00.
Read Our Latest Stock Analysis on EMN
Eastman Chemical Company Profile
(
Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
See Also

Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.